Who Just RaisedHouston, TX · Health Care · Form D filed Aug 27, 2026
Eos SENOLYTIX, Inc. raised $750K
Eos SENOLYTIX, Inc. is a pharmaceutical company based in Houston, Texas. In an amended Form D filed with the SEC on August 27, 2026, it reported raising $750,000 from 2 investors as part of an offering of up to $25,000,000. The first sale in the offering took place on June 4, 2026.
Eos SENOLYTIX is a longevity biotechnology company developing PTC-2105, a MitoXcel™ gerotherapeutic that targets the fundamental mechanisms of aging.
- 2nd Form D since 2026. Earlier new notices: Jun 12, 2026. All filings on EDGAR
- Still raising. $24.3M of the $25M offering was still unsold at filing.
$750K raised since 2020
1 Form D offering, as reported to the SEC. Amendments update a round; they aren't counted twice.
| Filed | Sold | Offering size | Investors |
|---|---|---|---|
| Jun 12, 2026 | $750K | $25M | 2 |
Placement agent: Floww Private Markets US Inc.
Lead score
31 out of 100
early raise still raising website found young company
Outreach kit How it works 1:21
A first message that shows you did your homework, written from this filing. Fill in the brackets and send.
Email · subject: Congrats on the new round
Hi [first name], Congrats on the new round. I saw the raise in your SEC filing. Teams at this stage usually start looking at [what you do] right after a round... [Your name]
LinkedIn note
Congrats on the new round. I work with [who you help] on [what you do] right after a raise. Open to connecting?
Call opener
Hi, this is [your name] from [company]. I am calling because you just filed a raise with the SEC...
Find the right person Founders & CEO · Finance · Operations · People & hiring · Sales & marketing
Track this company How it works 0:56
Saved to your dashboard pipeline, with a badge in Explore.
Loading your outreach kit…
The outreach kit is part of Pro. Copy-ready email, LinkedIn and call openers for every new raise, plus daily alerts for the companies you sell to.
Filing details
- Website
- eossenolytix.com
- Amount raised
- $750,000
- Offering size
- $25,000,000
- Investors so far
- 2
- Minimum investment
- $250,000
- First sale
- June 4, 2026
- Securities offered
- Equity, Options or warrants
- Exemption claimed
- Rule 506(b)
- Industry
- Pharmaceuticals
- Headquarters
- Houston, Texas
- Incorporated
- Delaware, 2024
- Entity type
- Corporation
Filings
| Filed | Form | Raised | Offering size | Investors | Source |
|---|---|---|---|---|---|
| D/A (amendment) | $750,000 | $25,000,000 | 2 | SEC filing |
Figures come from the company's own filing with the SEC and are shown as reported. How to read a Form D.
Updated · Raises in the week of Aug 24, 2026 · Health Care funding in Texas · August 2026 funding report
Similar raises
FibroBiologics, Inc.
Houston, TX · filed Oct 13
Fibrobiologics is treating and curing common chronic diseases with next generation fibroblast cell-based therapies.
6th Form D since 2025
NOVASPARK ENERGY Corp
Houston, TX · filed Oct 9
NovaSpark Energy deploys mobile atmospheric hydrogen generators delivering on-site hydrogen, power, and water for defense, drones, disaster response, and critical infrastructure.
First Form DStill raising
TMF1 Akido, LLC
Houston, TX · filed Oct 93rd Form D since 2020
Top Grain Technologies, Inc.
Houston, TX · filed Oct 7First Form DStill raising
Cosmetic Physician Partners, LLC
Dallas, TX · filed Oct 14
Cosmetic Physician Partners is the solution for Medical spas, Medical Aesthetics Clinics, plastic surgery clinics and cosmetic dermatology clinics.
11th Form D since 2021
Lucier Pharmaceuticals Inc.
Bryan, TX · filed Oct 13First Form D
Surgical Caregivers of Fort Worth, LLC
Fort Worth, TX · filed Oct 911th Form D since 2012
OncoNano Medicine, Inc.
Dallas, TX · filed Oct 84th Form D since 2018Still raising